Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Compounds from the plant Mammea siamensis may help treat hair loss.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Melandrium firmum extract helps mice grow hair by blocking a hair loss enzyme and changing hair growth genes.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Homeopathy can effectively treat pattern hair loss by using remedies like Lycopodium Clavatum and Natrum Muriaticum, tailored to the patient's overall condition.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

More research needed to confirm finasteride as standard treatment for FFA.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Treatments for hair loss vary, but cell-based options may be the future.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.